Endocrine Abstracts

Aim: Auger electron (AE)-emitting radionuclides are well suited as molecularly targeted radionuclide therapeutics (MRT) due to the high energy deposition density in the immediate vicinity of the decay site which avoids to a large extent non-specific radiotoxicity. However, due to the short range of the low-energy Auger (and Coster-Kronig) electrons, it is imperative that the AE emitting agent is closely associated with the cell nucleus. In this study we evaluate the dose depos...